[ Price : $8.95]
A Wiley Rein petition filed for a client asks FDA to order the immediate withdrawal of Wells Pharmas compounded 100 mg indomethaci...[ Price : $8.95]
FDA approves Shanghai Henlius Biologics Poherdy (pertuzumab-dpzb), the first interchangeable biosimilar to Genentechs Perjeta (per...[ Price : $8.95]
University of Chicago researchers explain how difficult it will be to improve government oversight over social media influencer pr...[ Price : $8.95]
FDA qualifies glutamate hydrogenase as a biomarker to enhance liver safety monitoring in clinical trials.[ Price : $8.95]
FDA introduces a new regulatory framework the plausible mechanism pathway designed to speed approval of highly personalized ther...[ Price : $8.95]
The CDER Office of Generic Drugs publishes a MAPP to help assessors use the four-part harmony approach in OGD-related communicatio...[ Price : $8.95]
Alkermes announces that its investigational once-daily therapy alixorexton significantly improved wakefulness and reduced daytime ...[ Price : $8.95]
A MAHA Summit on 11/19 will hear from vice president JD Vance, HHS secretary Robert F. Kennedy, Jr., and FDA commissioner Marty Ma...